Crinetics Pharmaceuticals Inc (CRNX) is a biotechnology company listed on US.
Latest reported CRNX revenue for 2025-12-31 was $7.7M. Net income was -$465.3M. CRNX currently screens at market cap $2.76B.
Use this CRNX page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the CRNX quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the CRNX SEC filings page. Lician reads the product cache first so this HTML stays unique to Crinetics Pharmaceuticals Inc even when a live quote feed is slow.
Latest cached year on this hub. Full CRNX income, balance, and cash tables.